Matt O'Brien

Matt O'Brien is a senior research analyst and managing director at Piper Sandler covering medical technology and devices. Before joining Piper Sandler in 2014, O'Brien covered medical technology at William Blair for 10 years. Additional work experience includes five years of middle-market investment banking financial advisory work and two years at a healthcare manufacturing and distribution company. O'Brien holds an MBA from the University of Chicago Booth School of Management and a Bachelor of Science from DePaul University in finance.

Universe Coverage

Medical Technology and Devices
ATEC	Alphatec Holdings, Inc.
APYX	Apyx Medical Corporation
ATRC	AtriCure, Inc.
BSX	Boston Scientific Corporation
CNMD	CONMED Corporation
DXCM	DexCom, Inc.
GKOS	Glaukos Corporation
GMED	Globus Medical, Inc.
PODD	Insulet Corporation
IART	Integra LifeSciences Holdings Corporation
MDT	Medtronic plc
KIDS	OrthoPediatrics Corp.
SYK	Stryker Corporation
TNDM	Tandem Diabetes Care, Inc.
TELA	TELA Bio, Inc.
TFX	Teleflex Incorporated
ZBH	Zimmer Biomet Holdings, Inc.
RCEL	AVITA Medical, Inc.
SGHT	Sight Sciences, Inc.
CVRX	CVRx, Inc.
FNA	Paragon 28, Inc.
UTRS	Minerva Surgical, Inc.
MIRO	Miromatrix Medical, Inc.
PEN	Penumbra, Inc.
ITGR	Integer Holdings Corp.
OBIO	Orchestra Biomed Holdings, Inc.
STAA	STAAR Surgical Company
PRCT	PROCEPT BioRobotics Corp.